5 Best Biotech Stocks to Buy Under $20

3. Roivant Sciences Ltd. (NASDAQ:ROIV)

Number of Hedge Fund Investors in Q4 2022: 35

Roivant Sciences Ltd. (NASDAQ:ROIV) develops treatments for tumors, sickle cell diseases, dermatitis, psoriasis, anemia, eye problems, and other problems. It is headquartered in London, the United Kingdom.

Insider Monkey profiled 943 hedge fund portfolios for their fourth quarter of 2022 investments and found out that 35 had invested in Roivant Sciences Ltd. (NASDAQ:ROIV). Daniel Gold’s QVT Financial is the company’s largest investor as it owns 122 million shares that are worth $979 million.

Follow Roivant Sciences Ltd.